ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      AI Subscribe Login/Register Profile Icon
      S&P 500
      5,867.08
      -0.09%
      US Tech 100
      20,468.00
      -0.92%
      Dow Jones
      42,342.24
      0.04%
      Brent Oil
      72.345
      -0.06%
      Bitcoin
      96,709.63
      -0.77%
      Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. Europe
      5. EU

      6. Global Bioenergies (ALGBE) Quote

      Global Bioenergies

      Global Bioenergies (ALGBE)

      EU
      0.833
      0.00
      (0.00%)
      Closed December 20 11:30AM
      Delayed by 15 minutes

      Professional-Grade Tools, for Individual Investors.

      Premium

      Key stats and details

      Current Price
      0.833
      Bid
      0.71
      Ask
      0.858
      Volume
      0.00
      0.00 Day's Range 0.00
      0.432 52 Week Range 2.165
      Market Cap
      15.11M
      Previous Close
      0.833
      Open
      -
      Last Trade
      Last Trade Time
      Financial Volume
      -
      VWAP
      -
      Average Volume (3m)
      69,226
      Shares Outstanding
      18,138,892
      Dividend Yield
      -
      PE Ratio
      -1.74
      Earnings Per Share (EPS)
      -0.48
      Revenue
      7.34M
      Net Profit
      -8.66M

      About Global Bioenergies

      Sector
      Misc Retail Stores, Nec
      Industry
      Biological Pds,ex Diagnstics
      Website
      www.global-bioenergies.com
      Headquarters
      Evry, Essonne, Fra
      Founded
      2021
      Global Bioenergies is listed in the Misc Retail Stores sector of the Euronext with ticker ALGBE. The last closing price for Global Bioenergies was 0.83 €. Over the last year, Global Bioenergies shares have traded in a share price range of 0.432 € to 2.165 €.

      Global Bioenergies currently has 18,138,892 shares outstanding. The market capitalization of Global Bioenergies is 15.11 € million. Global Bioenergies has a price to earnings ratio (PE ratio) of -1.74.

      Ask ADVFN Intelligence (AI)

      ALGBE Latest News

      More News

      Global Bioenergies publie son rapport financier semestriel 2024

      Global Bioenergies publie son rapport financier semestriel 2024 COMMUNIQUE DE PRESSE Global Bioenergies publieson rapport financier semestriel 2024 Evry, le 29 octobre 2024 – 17h45 : Global...

      October 29 2024
      UK Regulatory

      Global Bioenergies ne parvient pas à financer son projet d’usine dédiée à la cosmétique, et consacre désormais tous ses efforts aux opportunités dans le SAF

      Global Bioenergies ne parvient pas à financer son projet d’usine dédiée à la cosmétique, et consacre désormais tous ses efforts aux opportunités dans le SAF COMMUNIQUE DE PRESSE Global...

      October 17 2024
      UK Regulatory

      Unable to get its cosmetics plant project financed, Global Bioenergies is now focusing all its efforts on SAF opportunities

      Unable to get its cosmetics plant project financed, Global Bioenergies is now focusing all its efforts on SAF opportunities PRESS RELEASE Unable to get its cosmetics plant project financed...

      October 17 2024
      UK Regulatory

      Unable to get its cosmetics plant project financed, Global Bioenergies is now focusing all its efforts on SAF opportunities

      PRESS RELEASE Unable to get its cosmetics plant project financed, Global Bioenergies is now focusing all its efforts on SAF opportunities Evry, 17 October 2024 – 07:30 a.m.: After several months...

      October 17 2024
      GlobeNewswire Inc.

      Global Bioenergies : perte nette réduite à -2,8 M€ au premier semestre 2024

      Global Bioenergies : perte nette réduite à -2,8 M€ au premier semestre 2024 COMMUNIQUE DE PRESSE Global Bioenergies : perte nette réduite à -2,8 M€au premier semestre 2024 Perte nette réduite à...

      September 10 2024
      UK Regulatory

      Global Bioenergies: net loss reduced to €2.8m in first-half 2024

      PRESS RELEASE Global Bioenergies: net loss reduced to €2.8min first-half 2024 Net loss reduced to -2.8 M€ compared to -€4.1 million in H1 2023and -€5.8 million for H1 2022 Gross cash position...

      September 10 2024
      GlobeNewswire Inc.

      Global Bioenergies: net loss reduced to €2.8m in first-half 2024

      Global Bioenergies: net loss reduced to €2.8m in first-half 2024 PRESS RELEASE Global Bioenergies: net loss reduced to €2.8min first-half 2024 Net loss reduced to -2.8 M€ compared to -€4.1...

      September 10 2024
      UK Regulatory

      Bilan semestriel du contrat de liquidité au 28/06/2024

      Bilan semestriel du contrat de liquidité au 28/06/2024 COMMUNIQUE DE PRESSE Bilan semestriel du contrat de liquidité au 28/06/2024 Evry, le 26 juillet 2024 – 17h45 : Global Bioenergies (Euronext...

      July 26 2024
      UK Regulatory

      Global Bioenergies devient membre du GIFAS

      Global Bioenergies devient membre du GIFAS COMMUNIQUE DE PRESSE Global Bioenergies devient membre du GIFAS Evry, le 16 juillet 2024 – 17h45 : Après avoir été sélectionné par un jury d’experts...

      July 16 2024
      UK Regulatory

      Global Bioenergies becomes a member of GIFAS

      PRESS RELEASE Global Bioenergies becomes a member of GIFAS Evry, 16 July 2024 – 05:45 p.m.: After successfully passing a selection process led by a panel of experts, Global Bioenergies joins the...

      July 16 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      10.0151.83374083130.8180.8580.786231860.83176346DE
      40.0536.794871794870.780.8770.77235030.82612853DE
      12-0.615-42.47237569061.4481.550.432692260.90475227DE
      26-0.787-48.58024691361.621.950.432400671.07658179DE
      52-1.247-59.95192307692.082.1650.432302701.36027681DE
      156-3.617-81.28089887644.455.990.432330812.84332171DE
      260-1.957-70.14336917562.799.940.432502704.7368807DE

      ALGBE - Frequently Asked Questions (FAQ)

      What is the current Global Bioenergies share price?
      The current share price of Global Bioenergies is 0.833 €
      How many Global Bioenergies shares are in issue?
      Global Bioenergies has 18,138,892 shares in issue
      What is the market cap of Global Bioenergies?
      The market capitalisation of Global Bioenergies is EUR 15.11M
      What is the 1 year trading range for Global Bioenergies share price?
      Global Bioenergies has traded in the range of 0.432 € to 2.165 € during the past year
      What is the PE ratio of Global Bioenergies?
      The price to earnings ratio of Global Bioenergies is -1.74
      What is the cash to sales ratio of Global Bioenergies?
      The cash to sales ratio of Global Bioenergies is 2.05
      What is the reporting currency for Global Bioenergies?
      Global Bioenergies reports financial results in EUR
      What is the latest annual turnover for Global Bioenergies?
      The latest annual turnover of Global Bioenergies is EUR 7.34M
      What is the latest annual profit for Global Bioenergies?
      The latest annual profit of Global Bioenergies is EUR -8.66M
      What is the registered address of Global Bioenergies?
      The registered address for Global Bioenergies is 5 RUE HENRI DESBRUERES, EVRY, ESSONNE, 91000
      What is the Global Bioenergies website address?
      The website address for Global Bioenergies is www.global-bioenergies.com
      Which industry sector does Global Bioenergies operate in?
      Global Bioenergies operates in the BIOLOGICAL PDS,EX DIAGNSTICS sector

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      ABCAABC Arbitrage
      4.66 €
      (0.00%)
      		0
      ABAb Science
      0.928 €
      (0.00%)
      		0
      AALBAalberts NV
      33.54 €
      (0.00%)
      		0
      AAAAlan Allman Associates
      4.00 €
      (0.00%)
      		0
      74SW74Software SA
      27.50 €
      (0.00%)
      		0
      ABCAABC Arbitrage
      4.66 €
      (0.00%)
      		0
      ABAb Science
      0.928 €
      (0.00%)
      		0
      AALBAalberts NV
      33.54 €
      (0.00%)
      		0
      AAAAlan Allman Associates
      4.00 €
      (0.00%)
      		0
      74SW74Software SA
      27.50 €
      (0.00%)
      		0
      ABCAABC Arbitrage
      4.66 €
      (0.00%)
      		0
      ABAb Science
      0.928 €
      (0.00%)
      		0
      AALBAalberts NV
      33.54 €
      (0.00%)
      		0
      AAAAlan Allman Associates
      4.00 €
      (0.00%)
      		0
      74SW74Software SA
      27.50 €
      (0.00%)
      		0

      Discussion

      View Full Feed
      jhdf51 jhdf51 5 minutes ago
      My bird in the hand is COOP. Escrow is now a ROC
      capable of carrying hopeful escrowers in its talons.

      JHD
      COOP
      jhdf51 jhdf51 8 minutes ago
      It seems that people playing options are like people going to Vegas.. they never lose.

      JHD
      COOP
      2018trader 2018trader 9 minutes ago
      Just keep buying the monopoly 7, I mean mag 7
      SPY
      TCI1 TCI1 9 minutes ago
      I can’t open the link to the CVS coverage for 2025, would like to see it as they dropped Vascepa in July.

      Sleven have you seen any positive or negative changes?
      CVS
      TCI1 TCI1 11 minutes ago
      Well UHC has both IPE and Vascepa covered with PA so you would hope and expect all CVD indications to go to Vascepa. Not sure if this is a change or not but by using a PA UHC are exposing themselves to litigation if they prioritise generic for CVD. Of course this is based off insurers adhering to th
      AMRN
      Real McCoy Real McCoy 13 minutes ago
      Yes. In this case the assets were acquired. A long time ago. Right?
      THEDOG 17 THEDOG 17 15 minutes ago
      Sorry I can read !! Obviously you can’t. Acquisition-is that not a real word?
      devil dog 96 devil dog 96 22 minutes ago
      Their O/S has been unchanged since 2021. These guys protect their share structure + they are great at marketing. Can't wait for them to be ready to fire up their next story. She is setup for some silver with how light they have kept her. Heck she has not had an RS since 2009 like 16 years ago and sh
      CRSM
      newmedman newmedman 26 minutes ago
      That's the GOP "man date" ;-)
      go seek go seek 27 minutes ago
      Well, in this game one soon learns that the race is not a sprint. At least that’s my experience. We are all puzzled by the price drop since 24 October. We could debate the drop ad infinitum. I don’t understand it, and probably never will. GLTA
      ENTA
      Viewmont Viewmont 29 minutes ago
      It looks like we don't read the news or reports anymore.
      They've been yelling that they're getting ready to submit it for FDA approval! LOL.
      No need to do any DD, just rely on the next guy.

      https://x.com/ADHCMANAGEMENT/status/1866858719339823271
      https://x.com/ADH
      ADHC
      north40000 north40000 29 minutes ago
      Am I correct that all LTCLs and STCLs currently can be used by either spouse to offset any corresponding LTCGs and STCGs accruing in taxable account(s) in any year before death of either spouse?
      AMRN
      Remember Tomorrow Remember Tomorrow 33 minutes ago
      I hate it when I get my Schwartz twisted.

      RT
      XRPUSD
      diversified holdings diversified holdings 34 minutes ago
      Beautiful! $$$$RNVA$$$$ Thanks satter.
      RNVA
      nowwhat2 nowwhat2 36 minutes ago
      Crypto Christmas Bazaar🎅🧑‍🎄


      https://investorshub.advfn.com/uimage/uploads/2024/12/20/mjqinBTC_121212_19_XRP_45d_10PM_GRINCH_CALVIN.jpg


      https://www.youtube.com/watch?v=MnRLk5jQC2M

      https://www.youtube.com/watch
      BTCUSD
      Real McCoy Real McCoy 36 minutes ago
      Sorry it’s dead due to liquidation more than 6 years ago.

      It’s hard to believe you gave up at 4 years only to come back at 6 like there’s a chance.
      europa7 europa7 37 minutes ago
      Hedera (HBAR) Gains Institutional Momentum as Tech Giants and Financial Markets Embrace Network
      December 20, 2024
      https://www.fxleaders.com/news/2024/12/20/hedera-hbar-gains-institutional-momentum-as-tech-giants-and-financial-markets-embrace-network/
      HBARUSD
      bigstocksnbonds bigstocksnbonds 42 minutes ago
      You are doing the right thing to complain to the Corporate Headquarters!! Right thing bravo!!

      It only takes one bad apple to spoil things!!!!  
      2018trader 2018trader 43 minutes ago
      Just keep buying the monopoly 7, I mean mag 7
      SPY
      KILLAZILLA KILLAZILLA 44 minutes ago
      That wasn't a question DUMBASS!!!

      XERI
      devil dog 96 devil dog 96 48 minutes ago
      Looking forward to all the marketing they will be doing. The S1 sounds promising we will get the marketing we have all been waiting for. 🔥

      " Reading the S1 from the company can be enlightening.
      Not being able to, not so much "

      The no proof scam theory pro
      ATMH
      dinogreeves dinogreeves 48 minutes ago
      Ten years waiting and no sweating is not human. Either way, good luck.
      NXPL
      nowwhat2 nowwhat2 50 minutes ago
      Crypto Christmas Bazaar🎅🧑‍🎄

      https://investorshub.advfn.com/uimage/uploads/2024/12/20/mjqinBTC_121212_19_XRP_45d_10PM_GRINCH_CALVIN.jpg


      https://www.youtube.com/watch?v=MnRLk5jQC2M

      https://www.youtube.com/watch?v=ratq3
      XRPUSD
      TRAPPER JIM TRAPPER JIM 51 minutes ago
      Made all my deliveries and pickups today. The new terminal manager has been harassing me all week this week. I called the corporate office and told them how bad he was treating the drivers. So he is not dealing well with it. I don't care though. I called him a liar this morning. He turned me into HR

      Your Recent History

      EU
      ALGBE
      Global Bioenergies
      Delayed Upgrade Clock

      Go Ad-Free

      Subscribe to Ad free and enjoy an ad-free experience

      No Ads

      Try Now

      Keep the Ads